Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

7.150 +0.250 (+3.62%)
Official Closing Price Updated: 4:47 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
Bionano Genome Imaging Identifies the Most Common Structural Variations Between Individuals with DiGeorge Syndrome
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Actinium Pharmaceuticals, General Electric, Delta Air Lines, or TOP Ships?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, ATNM, GE, DAL, and TOPS. 
From PR Newswire
First Publication from International Consortium Using Bionano Imaging in Genetic Disease Patients Demonstrates that Bionano’s Saphyr Detects All 100 Chromosomal Aberrations in 85 Samples
From GlobeNewswire News Releases
Thinking about buying stock in Nio Inc, Delta Air Lines, Houghton Mifflin Harcourt, Royal Caribbean Cruises, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for NIO, DAL, HMHC, RCL, and BNGO. 
From PR Newswire
Bionano Genomics Data is Essential Part of the First Ever Complete Assembly of a Human X-Chromosome
Bionano’s Saphyr data was considered the gold standard for structural accuracy used to correct structural errors in the assembly 
From GlobeNewswire News Releases
Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis
Bionano’s new Bionano Prep™ SP Tissue and Tumor Kit enables routine analysis of cancer biopsies and animal tissue expanding its addressable market to include solid tumors and model genomes commonly... 
From GlobeNewswire News Releases
First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standin
From GlobeNewswire News Releases
The UK NHS, the Medical College of Wisconsin, and the Leading South Korean Yonsei University Hospital are Among Newest Adopters of Bionano Saphyr® for Digital Cytogenetic Applications
Represents continued growth of the installed base of Saphyr systems for its use in resolving complex genetic disease cases and simplifying cytogenetic workflows across the world 
From GlobeNewswire News Releases
Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update
Company to host conference call today, Thursday, June 18, at 4:30 pm ET 
From GlobeNewswire News Releases
Bionano Announces Amendment to Proxy Statement for Annual Meeting of Stockholders
Amendment Extends Deadline for Board to Effect or Abandon Reverse Split Amendment 
From GlobeNewswire News Releases
Bionano Genomics to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on June 18
From GlobeNewswire News Releases
Data Presented at European Society of Human Genetics (ESHG) Conference Shows Saphyr System has 100% Concordance with Standard Cytogenetics in Leukemias and Constitutional Aberrations
From GlobeNewswire News Releases
Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device
From GlobeNewswire News Releases
Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing
From GlobeNewswire News Releases
Cancer Genomics Consortium Members Demonstrate 100% Concordance Between Bionano Saphyr and Gold Standard Cytogenetics in Leukemia
Saphyr identifies all variants detected by the standard of care in cytogenetics in over 100 leukemia samples 
From GlobeNewswire News Releases
Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020
From GlobeNewswire News Releases
Bionano Genomics Adds Healthcare and Genomics Industry Experts with Experience in Commercialization and Reimbursement to Its Board of Directors
Appointments add proven business leadership with strategic knowledge of commercialization of diagnostics to support Bionano’s mission of developing solutions in digital cytogenetics and genomics... 
From GlobeNewswire News Releases
Largest North American Site for FSHD Muscular Dystrophy Testing Adopts Bionano Genomics’ Saphyr for Majority of Clinical Tests
University of Iowa to use Bionano-based assay to replace most “gold standard” Southern blot tests for molecular diagnosis of FSHD 
From GlobeNewswire News Releases
NetworkNewsBreaks – Bionano Genomics, Inc. (NASDAQ: BNGO) Closes $18M Follow-On
From InvestorBrandNetwork
BIONANO GENOMICS ANNOUNCES PRICING OF $18 MILLION UNDERWRITTEN PUBLIC OFFERING
From GlobeNewswire News Releases
Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility
Bionano Genomics, Rescale, Amazon Web Services, and Genoox are donating consumables and compute resources to this effort based in Hannover, Germany 
From GlobeNewswire News Releases
Three Top European Sites Adopt Bionano Saphyr® for Cancer, Genetics, and Cytogenetic Applications
Curie Institute in France, NHS Lothian Edinburgh in Scotland, and MVZ Martinsried in Germany choose Bionano to solve unanswered questions in human genetic variation and in cytogenetic applications 
From GlobeNewswire News Releases
Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility
First study to be based in Wuhan, China; European and North American studies expected to follow 
From GlobeNewswire News Releases
Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update
Conference Call and Webcast scheduled for today, Thursday, March 5 at 4:30 pm ET 
From GlobeNewswire News Releases
Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5
From GlobeNewswire News Releases
Bionano Genomics Releases Saphyr Updates for Industry-Leading Data Yields that Enable Analysis of Complex Cancer Samples at Unprecedented Depths
Bionano now offering genome analysis services and reagent rental options making it easier than ever for scientists and clinicians to get Bionano Data 
From GlobeNewswire News Releases
Bionano Genomics Data Drives Scientific Discoveries in Solid Tumors and Leukemias, To Be Presented at the 2020 AGBT Conference
Top researchers present their discoveries using Bionano’s genome imaging technology 
From GlobeNewswire News Releases
Bionano Genome Imaging Concordant with Traditional Cytogenetics in Landmark Leukemia Study
Bionano identifies all clinically reported variants detected by karyotyping, CNV-microarray and FISH combined in 48 leukemia genomes 
From GlobeNewswire News Releases
Users of Bionano Genomics’ Saphyr System to Present Reference Genome Assembly and SV Discovery for Plant and Animal Genomes at the PAG XXVIII Conference
Presenters are scheduled to discuss Saphyr’s impact for applications in plant and animal research 
From GlobeNewswire News Releases
Bionano Genomics’ Saphyr® System is Adopted by GeneDx for the Clinical Detection of Genetic Variants in Muscular Dystrophies, Developmental and Reproductive Disorders
A new generation of Bionano-based assays to be brought to the clinic by GeneDx 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.